David Schubert

Company: Roche
Job title: Principal Scientist
Seminars:
A Novel IgG-IL2 Mutein to Selectively Activate T Regulatory Cells 2:45 pm
• Design and development of an IL-2 mutein showing Treg specificity • Assessment of Treg pharmacology in vitro and in vivo in non-clinical studies • Path towards clinical development of Treg therapies using IL-2 muteinsRead more
day: Day One